Summary
India's pharmaceutical sector is projected to miss its 2030 sales target, now estimated at $80-90 billion instead of $130 billion. This shortfall is attributed to uncertainties from US tariffs and shipping disruptions in the Middle East, according to Namit Joshi, Chairman of the Pharmaceuticals Export Promotion Council of India.